Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Ablynx NV ADS (delisted) (ABLX)
Ablynx NV ADS (delisted) (ABLX) Actualités

ABLX

Ablynx NV (ABLX)

Ablynx NV ADS (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ABLX

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
19/06/2018	07h00	GlobeNewswire	SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE	NASDAQ:ABLX	Ablynx NV ADS (delisted)
28/05/2018	07h05	GlobeNewswire	PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (...	NASDAQ:ABLX	Ablynx NV ADS (delisted)
25/05/2018	19h00	GlobeNewswire	NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020	NASDAQ:ABLX	Ablynx NV ADS (delisted)
17/05/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES WARRANT EXERCISE	NASDAQ:ABLX	Ablynx NV ADS (delisted)
14/05/2018	08h57	Dow Jones News	Sanofi-Ablynx Deal Goes Ahead	NASDAQ:ABLX	Ablynx NV ADS (delisted)
14/05/2018	08h00	GlobeNewswire	SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-O...	NASDAQ:ABLX	Ablynx NV ADS (delisted)
30/04/2018	07h00	GlobeNewswire	ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171	NASDAQ:ABLX	Ablynx NV ADS (delisted)
29/03/2018	07h00	GlobeNewswire	PREVIOUSLY ANNOUNCED TENDER OFFERS BY SANOFI TO ACQUIRE ABLYNX WILL COMMENCE ON APRIL 4, 2018	NASDAQ:ABLX	Ablynx NV ADS (delisted)
26/03/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES TOPLINE RESULTS FROM THE PHASE II STUDY OF VOBARILIZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	NASDAQ:ABLX	Ablynx NV ADS (delisted)
02/03/2018	07h00	GlobeNewswire	ABLYNX COMMENCES DOSING IN ITS PHASE II STUDY OF ALX-0171 IN HOSPITALISED JAPANESE INFANTS WITH A RSV INFECTION	NASDAQ:ABLX	Ablynx NV ADS (delisted)
01/03/2018	11h19	Dow Jones News	Sanofi Receives Antitrust Clearances in U.S., Germany for Ablynx Acquisition	NASDAQ:ABLX	Ablynx NV ADS (delisted)
28/02/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES CONVERSION OF BONDS	NASDAQ:ABLX	Ablynx NV ADS (delisted)
22/02/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES 2017 FULL YEAR RESULTS	NASDAQ:ABLX	Ablynx NV ADS (delisted)
16/02/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES	NASDAQ:ABLX	Ablynx NV ADS (delisted)
07/02/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES BOARD CHANGES	NASDAQ:ABLX	Ablynx NV ADS (delisted)
30/01/2018	09h02	Dow Jones News	Sanofi To Acquire Belgian Biotech -- WSJ	NASDAQ:ABLX	Ablynx NV ADS (delisted)
29/01/2018	11h59	Dow Jones News	Novo Nordisk Confirms It Will Not Make Revised Bid for Ablynx	NASDAQ:ABLX	Ablynx NV ADS (delisted)
29/01/2018	11h54	Dow Jones News	Sanofi to Buy Ablynx for $4.85 Billion -- Update	NASDAQ:ABLX	Ablynx NV ADS (delisted)
29/01/2018	09h06	Dow Jones News	Sanofi to Acquire Ablynx for EUR3.9 Billion	NASDAQ:ABLX	Ablynx NV ADS (delisted)
29/01/2018	08h19	GlobeNewswire	SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION	NASDAQ:ABLX	Ablynx NV ADS (delisted)
24/01/2018	07h00	GlobeNewswire	ABLYNX APPOINTS DR ROBERT FRIESEN AS CHIEF SCIENTIFIC OFFICER	NASDAQ:ABLX	Ablynx NV ADS (delisted)
22/01/2018	07h00	GlobeNewswire	ABLYNX ANNOUNCES WARRANTS EXERCISE AND CONVERSION OF BONDS	NASDAQ:ABLX	Ablynx NV ADS (delisted)
09/01/2018	09h02	Dow Jones News	Drug Firm Rejects $3.13 Billion Offer From Novo Nordisk -- WSJ	NASDAQ:ABLX	Ablynx NV ADS (delisted)
08/01/2018	13h25	GlobeNewswire	ABLYNX STRONGLY BELIEVES UNSOLICITED CONDITIONAL PROPOSAL FROM NOVO NORDISK FUNDAMENTALLY UNDERVALUES THE COMPANY AND ITS FUT...	NASDAQ:ABLX	Ablynx NV ADS (delisted)
08/01/2018	08h30	Dow Jones News	Belgium's Ablynx Rejects EUR2.6 Billion Bid From Novo Nordisk	NASDAQ:ABLX	Ablynx NV ADS (delisted)
04/01/2018	07h00	GlobeNewswire	ABLYNX TO PRESENT AT THE 36th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	NASDAQ:ABLX	Ablynx NV ADS (delisted)
27/12/2017	07h00	GlobeNewswire	NOTICE IN RELATION TO WAIVER OF LOCK-UP RESTRICTION	NASDAQ:ABLX	Ablynx NV ADS (delisted)
21/12/2017	07h00	GlobeNewswire	ABLYNX ANNOUNCES POSITIVE DATA FROM ITS JAPANESE ETHNO-BRIDGING STUDY OF CAPLACIZUMAB	NASDAQ:ABLX	Ablynx NV ADS (delisted)
12/12/2017	13h40	GlobeNewswire	ABLYNX REPORTS ADDITIONAL CLINICALLY IMPORTANT BENEFITS OF CAPLACIZUMAB FROM ITS PHASE III HERCULES STUDY IN ACQUIRED TTP	NASDAQ:ABLX	Ablynx NV ADS (delisted)
07/12/2017	07h00	GlobeNewswire	ABLYNX WILL HOST A WEBCAST TO DISCUSS ADDITIONAL DATA FROM ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB IN ACQUIRED TTP FOLLO...	NASDAQ:ABLX	Ablynx NV ADS (delisted)